Data / Drug companies / Sthree Chemicals Private Limited
Sthree Chemicals Private Limited: 50 products in the FDA NDC directory, labeler code 83511
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Sthree Chemicals Private Limited (labeler code 83511) lists 50 products in the FDA National Drug Code Directory. By type: 50 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on October 13, 2026.
The request: Watch Sthree Chemicals Private Limited (FDA labeler code 83511): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 83511
- Products in commercial distribution
- 50
- Packages
- 350
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule III 3, Schedule IV 1
- Started marketing in the last 12 months
- 16
- Earliest marketing start
- December 9, 2024
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 50 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 50 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 50 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Vamorolone | 83511-053 | Powder | Bulk ingredients | October 13, 2026 |
| Gepirone hydrochloride | 83511-052 | Powder | Bulk ingredients | September 16, 2026 |
| Tedizolid phosphate | 83511-051 | Powder | Bulk ingredients | September 16, 2026 |
| Tenapanor hydrochloride | 83511-050 | Powder | Bulk ingredients | September 16, 2026 |
| Resveratrol | 83511-049 | Powder | Bulk ingredients | September 1, 2026 |
| Tetracaine hydrochloride | 83511-047 | Powder | Bulk ingredients | August 21, 2026 |
| Tetracaine | 83511-046 | Powder | Bulk ingredients | August 21, 2026 |
| Flibanserin | 83511-045 | Powder | Bulk ingredients | August 17, 2026 |
| Clomiphene citrate | 83511-044 | Powder | Bulk ingredients | August 10, 2026 |
| Levoketoconazole | 83511-043 | Powder | Bulk ingredients | July 20, 2026 |
| Sparsentan | 83511-042 | Powder | Bulk ingredients | July 2, 2026 |
| Stanozolol | 83511-008 | Powder | Bulk ingredients | June 23, 2026 |
| Gatifloxacin | 83511-041 | Powder | Bulk ingredients | May 26, 2026 |
| Thiamine hydrochloride | 83511-039 | Powder | Bulk ingredients | December 27, 2025 |
| Pyridoxine hydrochloride | 83511-038 | Powder | Bulk ingredients | December 27, 2025 |
| Methenamine hippurate | 83511-037 | Powder | Bulk ingredients | December 16, 2025 |
| Biotin | 83511-009 | Powder | Bulk ingredients | October 28, 2025 |
| Cholic acid | 83511-036 | Powder | Bulk ingredients | October 17, 2025 |
| Methylnaltrexone bromide | 83511-035 | Powder | Bulk ingredients | September 29, 2025 |
| Progesterone | 83511-034 | Powder | Bulk ingredients | September 29, 2025 |
| Clemastine fumarate | 83511-016 | Powder | Bulk ingredients | September 29, 2025 |
| Treprostinil sodium | 83511-033 | Powder | Bulk ingredients | September 9, 2025 |
| Naltrexone hydrochloride | 83511-032 | Powder | Bulk ingredients | August 20, 2025 |
| Rivaroxaban | 83511-031 | Powder | Bulk ingredients | August 16, 2025 |
| Beta nicotinamide adenine dinucleotide | 83511-030 | Powder | Bulk ingredients | August 16, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.